Journal articleEur J Cancer2013
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
- Journal
- Eur J Cancer
- Published
- 28 May 2013
- Citations
- 33
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try